CA
NZ
UK
AU
IND
US
XFLH Capital Corporation filed a Form 8-K with the SEC on September 22, 2026, disclosing that it entered into a letter of intent on September 18, 2026, with Renogen Biolab Inc. for a proposed business combination.
Idaho Copper Corporation filed a Form 8-K with the SEC on September 22, 2026, disclosing that the U.S. Forest Service, Boise National Forest, approved the company's Exploration Plan of Operations and its 2026 annual operating plan for exploration at its project in Boise County, …
VICI Properties Inc. filed an amended current report (Form 8-K/A) on September 22, 2026, disclosing that John M. Sullivan's appointment to its Board of Directors became effective on September 18, 2026, following receipt of applicable regulatory approvals.
bioAffinity Technologies, Inc. filed a Form 8-K on September 22, 2026, disclosing that the company issued a press release announcing the presentation of two posters on its CyPath® Lung diagnostic at the 2026 NAVREF Annual Conference, scheduled for September 27-30, 2026, in Arlington, Virginia.
Columbus McKinnon Corporation filed a current report on Form 8-K on September 22, 2026, disclosing that it entered into a First Amendment to its Credit Agreement on September 21, 2026, refinancing its Term Loan B Facility and reducing the applicable interest rate margin on …
iPower Inc. filed a Form 8-K on September 22, 2026, disclosing the voting results from a special meeting of stockholders held on September 21, 2026, at which shareholders approved three proposals covering a stock offering authorization, a reverse stock split, and an amended equity …
Upbound Group, Inc. filed an 8-K with the SEC on September 22, 2026, disclosing the appointment of Scott Young as Executive Vice President and Chief Operating Officer, effective the same date.
Madison Square Garden Sports Corp. filed an 8-K on September 22, 2026, disclosing executive officer changes effective September 21, 2026, including the appointment of Jamaal T. Lesane as Executive Vice President and Chief Legal Officer.
Lucid Diagnostics Inc. filed a Form 8-K with the SEC on September 22, 2026, disclosing that it issued a press release announcing advances in payment, billing, and coding pathways for its EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device.
Caesars Entertainment, Inc. filed an 8-K on September 22, 2026, reporting that it received a stockholder demand letter on September 15, 2026, and voluntarily supplemented its definitive proxy statement to address allegations concerning its outside legal counsel's concurrent representations.
Please wait processing your request...